HTML Preview Student Curriculum Vitae page number 1.


Izna Ali, PharmD
EDUCATION
Doctor of Philosophy, Pharmaceutical Sciences August 2014-Present
Division of Pharmacotherapy and Experimental Therapeutics (DPET)
University of North Carolina Eshelman School of Pharmacy Chapel Hill, NC
Doctor of Pharmacy May 2014
Magna Cum Laude
Chicago College of Pharmacy, Midwestern University
Downers Grove, IL
Pre-pharmacy 2008-2010
Benedictine University Lisle, IL
LICENSURES/CERTIFICATIONS
2012 Cardiopulmonary Resuscitation/ BLS
2012 APhA Pharmacy-Based Immunization Delivery
2012 Alzheimer’s Association Community Representative
2010 – Present HIPAA Certified Midwestern University
2009 – March 2015 Student Pharmacist, Illinois State Board of Pharmacy
PROFESSIONAL EXPERIENCE
Student Pharmacist February 2010-Present
Target Pharmacy Naperville, IL
Supervisor: Dr. Brian Moran, Pharm.D, Pharmacy Manager
Receive new prescriptions via phone and interpret prescription orders from prescribers under the
supervision of the pharmacist.
Process insurance claims and resolve issues
Dispense medications and provide customer service
Counsel patients on proper prescription and over the counter medication use with the pharmacist’s
supervision
Clinical Pharmacology Summer Intern Summer 2012
Takeda Pharmaceuticals Deerfield, IL
Supervisor: Dr. Ronald Lee, PhD, Associate Director
Participated on project teams to provide guidance in the planning, management, and execution of clinical
pharmacology studies for clinical trials
Collaborated with pharmacometrics, analytical science, clinical science, non-clinical science and CMC
functions on pharmacokinetic related information
Verified clinical pharmacology data for accuracy on draft application prior to regulatory submission
Provided reviews of clinical pharmacokinetics within documents such as synopsis, protocols, investigator
brochures, clinical study reports and investigational medicinal product dossier to ensure the scientific
integrity and quality
Drafted the study synopsis for a food-effect study and the clinical pharmacology summary of a
bioavailability trial
Proposed clinical trial design for drug-drug interaction study based on known genetic polymorphisms of
statins
Investigated likely substrates that can be used to predict UGT mediated drug interactions
Conducted literature analysis and designed a presentation about genetic polymorphisms of drug transporters
and glucuronidation to the Exploratory and Translational Development Department
DOWNLOAD HERE


It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change. | Charles Darwin